Continuum Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$760K Buy
634
+179
+39% +$183K 0.26% 36
2026
Q1
$418K Hold
455
0.17% 46
2025
Q4
$489K Hold
455
0.19% 47
2025
Q3
$347K Buy
+455
New +$339K 0.15% 51
2024
Q3
Sell
-292
Closed -$264K 63
2024
Q2
$264K Buy
+292
New +$234K 0.14% 49

Other funds holding LLY

Continuum Wealth Advisors's LLY Position: Q2 2026 in Review

Continuum Wealth Advisors increased its Eli Lilly (LLY) stake by 39% in Q2 2026, buying an estimated $183K and bringing the position to 634 shares worth $760K. The position accounts for 0.26% of the portfolio, ranked #36.

Continuum Wealth Advisors first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Continuum Wealth Advisors held 634 shares of Eli Lilly worth $760K as of Q2 2026.
  • Continuum Wealth Advisors bought 179 Eli Lilly shares in Q2 2026, an estimated $183K.
  • Eli Lilly made up 0.26% of Continuum Wealth Advisors's portfolio in Q2 2026, its #36 holding.
  • Continuum Wealth Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Continuum Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.